Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Goldman Sachs Maintains Neutral on ACADIA Pharmaceuticals, Lowers Price Target to $15

Goldman Sachs Maintains Neutral on ACADIA Pharmaceuticals, Lowers Price Target to $15

Goldman Sachs analyst Salveen Richter maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Neutral and lowers the price target from $20 to $15.

byBenzinga Newsdesk

August 10, 2022

1 minute read

Goldman Sachs analyst Salveen Richter maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Neutral and lowers the price target from $20 to $15.

Prince Harry Called Gas-Guzzler And Hypocrite — Was The Report Incorrect?

By Chris Katje

August 31, 7:13 PM

Prince Harry was attacked by Fox News recently for being in a “gas-guzzling SUV.” Was the attack correct or unfounded?

FOX

Global
News

Reported Early Thursday, Seadrill Limited Commences Trading On The Oslo Stock Exchange

By Benzinga Newsdesk

November 17, 2:26 AM

Seadrill Limited ("Seadrill" or "the Company") (NYSE:SDRL) (OSE: SDRL) announces that it has successfully uplisted from Euronext Expand to the main list of the Oslo Stock Exchange

SDRL

India Races To Become Apple’s Biggest iPhone Manufacturing Hub After China As April Exports Surge Over $1B

By Shomik Sen Bhattacharjee

May 13, 5:37 AM

This story was first published on the Benzinga India portal.

AAPL

Nio Stock Is Trading Higher: What’s Going On?

By Adam Eckert

November 23, 1:02 PM

NIO Inc (NYSE: NIO) shares are trading higher Wednesday.

NIO

Goldman Sachs Maintains Neutral on ACADIA Pharmaceuticals, Lowers Price Target to $15

Related Posts

Prince Harry Called Gas-Guzzler And Hypocrite — Was The Report Incorrect?

Reported Early Thursday, Seadrill Limited Commences Trading On The Oslo Stock Exchange

India Races To Become Apple’s Biggest iPhone Manufacturing Hub After China As April Exports Surge Over $1B

Nio Stock Is Trading Higher: What’s Going On?